US: MITOTIX BOUGHT BY GERMAN GPC
Article Abstract:
Mitotix Inc., a Cambridge, Massachusetts-based cancer research firm, is being acquired by German Munich-based biotech company GPC AG. The deal takes place within a share swap, creating a company called GPC Biotech AG in Munich.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
GERMANY/US: CANCER R&D DEAL BY COLEY, LUDWIG
Article Abstract:
German Hilden-based Ludwig Institut fur Krebsforschung has signed a cooperation agreement with Coley Pharmaceuticals Group of Wellesley, Massachusetts, on the development of new cancer treatments on the basis of CpG DNA molecules.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
US: ROCHE INVESTS IN CANCER RESEARCH
Article Abstract:
Roche is injecting more than US$ 40mn in Tri-Path Imaging, a Burlington, North Carolina-based roducer of equipment and materials for cancer cell analysis. The Switzerland pharmaceutical maker thus raises its stake in Tri-Path to 26% and secures an option to raise it further to 36%.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2000
User Contributions:
Comment about this article or add new information about this topic: